Posted inStock
Earnings call: Bruker adjusts guidance amid biopharma, China challenges
Bruker (NASDAQ:BRKR) Corporation (NASDAQ: BRKR), a global scientific instruments company, has reported a revenue increase of 16.4% year-over-year in its third quarter of 2024, reaching $864.4 million. This growth was…